Dr. Srinubabu Gedela, CEO and Managing Director of OMICS Group
Dr. Srinubabu Gedela is the CEO and Managing Director of OMICS Group. OMICS Group is one of the world's biggest publishers of open access journals and the biggest organizer of Science conferences across the world. OMICS now has over 400 journals that publishes over 50000, scientific research articles every year, and alsorganizes over 100 conferences, congresses, summits, symposia and workshopsacross the world every year - and the organization is ever expanding. OMICS currently employs about 700 staff across India, USA and Romania.
The OMICS Group CEO Dr. Srinubabu Gedela was born in the village of Allena in Vishakhapatnam, South India. Dr. Gedela received his primary education from a school in his village before moving to complete his higher education from Andhra University, India. Dr. Srinubabu Gedela pursued B. Pharmacy, followed by M. Tech in Biotechnology from Andhra University, India and postdoctoral studies at Stanford University in the US. His deep interest in biotechnology, quest for knowledge and the computational methods to develop new methodologies bagged him the Young Scientist Award. Under the guidance of Dr. Allam Appa Rao, he completed his research on microanalysis of differentially expressed genes between the diabetic and non-diabetics. The paper was presented at an international conference at Seoul in 2007.
While at Stanford University for his postdoctoral research, Dr. Gedela interacted with many scholars and was invited at several other conferences in Europe and Asia Pacific. The open access journal of Proteomics was the first publication by Dr. Srinubabu Gedela, which laid the foundation of OMICS Group as the publisher of open access literature with the launch of its first journal. The OMICS Group added several open access journals to its portfolio, and Dr. Gedela also ensured regular interaction with the scientists from various disciplines. The OMICS Group Conferences holds conferences in various fields bringing together experts in the relevant industries onto a single platform and thereby accomplishing its aim of accelerating knowledge across the world.
OMICS did not start as an organization to make money. In 2007, Dr. Srinubabu went to do his research in science at Stanford University, United States of America. Coming from a modest Indian background, Dr. Srinu faced difficulty in accessing knowledge to produce research paper on Human Proteome Organization. His research earned him 'The Young Scientist' award in Seoul, Korea but his strong desire was to free up the scientific knowledge from all commercial barriers and hence he started OMICS. OMICS, unlike other publishing houses provides all medical, scientific, clinical and pharmaceutical knowledge for free and this gives a level playing field for young scientists from developing countries to be at par with their counterparts from developed world. During the process of publishing, the editorial board meetings happened to seed conferences.